Jump to content

Recommended Posts

On this episode of Let’s be Blunt, Montel talks with Michael Sassano, CEO of Somai Pharmaceuticals, a large-scale manufacturer of medical canna compounds based in Portugal. His experience as both a developer and banker in the United States and Europe provides a unique perspective towards navigating international rules and regulations for developing canna medicines.



Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Create New...